Skip to content Skip to main navigation Skip to footer

Volume 34, No 4, 2023

Article references:

Scroll down on page to see references for entire issue.

test this link

Academy News

The importance of clinical innovations

By: Robert J. Miller, DDS; Academy News Editorial Consultant, and Past Chairman of the AO Clinical Innovations Committee

References

  1. Sullivan, H., & Atkins, J. (1968) Free autogenous gingival grafts. I. Principles of successful grafting. Periodontics 6, 121–129
  2. Zuhr O, Baumer D, Hurzeler M. The addition of soft tissue replacement grafts in plastic periodontal and implant surgery: critical elements in design and execution. J Clin Periodontol. 2014;41(Suppl 15):S123-S142
  3. Balas EA, Boren SA Yearbook of Medical Informatics: Managing Clinical Knowledge for Health Care Improvement. Stuttgart, Germany: Schattauer Verlagsgesellschaft mbH; 2000 [PubMed] [Google Scholar]

The Role of Inflammation in Periodontitis and Peri-implantitis

By: Thomas E. Van Dyke, DDS, PhD; Academy News Guest Editor

References

  1. Marsh PD. Microbial ecology of dental plaque and its significance in health and disease. Advances in dental research 1994;8:263-271.
  2. Singh VP, Proctor SD, Willing BP. Koch’s postulates, microbial dysbiosis and inflammatory bowel disease. Clin Microbiol Infect. (2016) 22:594–9. doi: 10.1016/j.cmi.2016.04.018
  3. Riep B, Edesi-Neuss L, Claessen F, Skarabis H, Ehmke B, Flemmig TF, et al. Are putative periodontal pathogens reliable diagnostic markers? J Clin Microbiol. (2009) 47:1705–11. doi: 10.1128/JCM.01387-08
  4. Kumar, P. S., E. J. Leys, J. M. Bryk, F. J. Martinez, M. L. Moeschberger, A. L. Griffen. Changes in periodontal health status are associated with bacterial community shifts as assessed by quantitative 16S cloning and sequencing. J Clin Microbiol. (2006) 44:3665-3673.
  5. Page RC, Kornman KS. The pathogenesis of human periodontitis: an introduction. Periodontol. 2000. (1997) 14:9–11. doi: 10.1111/j.1600-0757.1997.tb00189.x
  6. Lamont RJ, Koo H, Hajishengallis G. The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol. (2018) 16:745–59. doi: 10.1038/s41579-018-0089-x
  7. Hasturk H, Kantarci A, Goguet-Surmenian E, Blackwood A, Andry C, Serhan CN, et al. Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J Immunol. (2007) 179 (10):7021-9
  8. Tanner ACR, Kent R Jr., Kanasi E, Lu SC, Paster BJ, Sonis ST, et al. Clinical characteristics and microbiota of progressing slight chronic periodontitis in adults. J Clin Periodontol. (2007) 34:917-30
  9. Tabas, I. & Glass, C. K. Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science. (2003) 339: 166–172.
  10. Serhan, C.N. et al. Novel functional sets of lipid-derived mediators with anti-inflammatory actions generated from omega-3 fatty acids via cyclooxygenase2-nonsteroidal anti-inflammatory drugs and transcellular processing. J. Exp. Med. 192, 1197–1204 (2000).
  11. Bannenberg, G. L. et al. Molecular circuits of resolution: formation and actions of resolvins and protectins. J. Immunol. 174, 4345–4355 (2005).
  12. Serhan, C. N. et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196, 1025–1037 (2002).
  13. Hong, S., Gronert, K., Devchand, P. R.,Moussignac, R. L. & Serhan, C. N. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J. Biol. Chem. 278, 14677–14687 (2003).
  14. Serhan, C. N. et al. Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J. Exp. Med. 206, 15–23 (2009).
  15. Dalli J, Chiang N, Serhan CN. Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections. Nat Med. 2015;21(9):1071–1075.
  16. Dalli J, Colas RA, Serhan CN. Novel n-3 immu- noresolvents: structures and actions. Sci Rep. 2013;3:1940.
  17. Maderna, P. & Godson, C. Lipoxins: resolutionary road. Br J Pharmacol. (2009) 158: 947–959.
  18. Ferguson B, Bokka NR, Maddipati KR, Ayilavarapu S, Weltman R, Zhu L, Chen W, Zheng WJ, Angelov N, Van Dyke TE, Lee CT. Distinct profiles of specialized pro-resolving lipid mediators and corresponding receptor gene expression in periodontal inflammation. Frontiers in Immunology. 2020 ;11:1307.
  19. El-Sharkawy H, Aboelsaad N, Eliwa M, Darweesh M, Alshahat M, Kantarci A, et al. Adjunctive treatment of chronic periodontitis with daily dietary supplementation with omega-3 fatty acids and low-dose aspirin. J Periodontol. 2010;81(11):1635–43.
  20. Abdalla HB, Alvarez C, Wu YC, Rojas P, Hammock BD, Maddipati KR, Trindade-da-Silva CA, Soares MQS, Clemente-Napimoga JT, Kantarci A, Napimoga MH, Van Dyke TE. Soluble epoxide hydrolase inhibition enhances production of specialized pro-resolving lipid mediator and promotes macrophage plasticity. Br J Pharmacol. 2023 Jun;180(12):1597-1615. doi: 10.1111/bph.16009.
Back to top